+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aqueous Shunts & Stents for Glaucoma Market by Shunt (Non-Valved, Valved), Stent (Subconjunctival, Suprachoroidal, Trabecular Meshwork) - Global Forecast 2025-2030- Product Image
Aqueous Shunts & Stents for Glaucoma Market by Shunt (Non-Valved, Valved), Stent (Subconjunctival, Suprachoroidal, Trabecular Meshwork) - Global Forecast 2025-2030- Product Image
New

Aqueous Shunts & Stents for Glaucoma Market by Shunt (Non-Valved, Valved), Stent (Subconjunctival, Suprachoroidal, Trabecular Meshwork) - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6150853
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Unveiling the Critical Role of Aqueous Shunts and Stents in Transforming Glaucoma Management Through Vision-Saving Innovations

Glaucoma remains a leading cause of irreversible blindness worldwide, posing an escalating challenge to healthcare systems and patient quality of life. At the forefront of surgical innovation, aqueous shunts and stents have emerged as pivotal interventions for patients whose intraocular pressure proves unmanageable through pharmacological or laser therapies alone. These implanted devices facilitate the regulated outflow of aqueous humor, effectively reducing pressure to safeguard the optic nerve. Over the past decade, advances in biomaterials, device architecture, and surgical techniques have transformed clinical practice, enabling physicians to offer safer, more predictable outcomes.

As minimally invasive approaches gain traction, the industry has witnessed an evolution from traditional trabeculectomy procedures toward streamlined implantable solutions. This shift reflects both regulatory encouragement for less traumatic interventions and the growing demand for accelerated patient recovery. Consequently, the global community of ophthalmic surgeons has embraced a spectrum of shunt and stent options, each tailored to address unique anatomical and physiological considerations. To fully appreciate these developments, it is essential to understand the underlying mechanisms that drive device efficacy and the clinical evidence that underscores their role in contemporary glaucoma management.

Navigating the Paradigm Shift in Glaucoma Care Driven by Technological Breakthroughs and Evolving Patient Outcomes in Minimally Invasive Procedures

The landscape of glaucoma treatment has undergone a fundamental transformation driven by converging technological breakthroughs and evolving clinical priorities. In recent years, miniaturized implant designs have replaced complex filtration surgeries, thereby reducing perioperative complications and enhancing patient satisfaction. Surgeons now employ micro-invasive glaucoma surgery (MIGS) as a frontline option, reflecting a paradigm shift toward procedures that preserve conjunctival integrity and minimize postoperative scarring. These less invasive approaches allow for earlier intervention and broaden the therapeutic window, opening possibilities for patients who previously faced limited or high-risk surgical choices.

Innovations in device engineering have been equally significant. Next-generation stents feature biocompatible coatings, adjustable flow mechanisms, and modular architectures that facilitate customization. At the same time, refinements in imaging and delivery platforms have improved placement accuracy, translating into more consistent pressure control. Regulatory bodies have responded with expedited pathways for breakthrough devices that demonstrate safety and efficacy, further accelerating clinical adoption. As a result, the treatment continuum increasingly integrates targeted aqueous outflow modulation, enabling clinicians to fine-tune patient care with unparalleled precision. This ongoing revolution underscores the critical role of adaptive technologies in reshaping the future of glaucoma management.

Evaluating the Ripple Effects of United States Tariffs on Glaucoma Device Supply Chains and Strategic Implications for Industry Stakeholders

The introduction of new tariffs on imported ophthalmic devices in the United States has generated a series of strategic adjustments across the glaucoma treatment ecosystem. With duties slated to rise in 2025, manufacturers and distributors are reevaluating their supply chains to mitigate cost pressures. Many have accelerated negotiations with component fabricators and explored regional partnerships to diversify sourcing. These efforts aim to preserve competitive pricing while maintaining the high quality standards essential for implantable devices.

Furthermore, the tariff landscape has prompted device developers to revisit their manufacturing footprints. By expanding domestic assembly capabilities and strengthening relationships with local suppliers, several industry leaders have reduced exposure to cross-border frictions. Meanwhile, contract research organizations and clinical trial sites have accelerated site initiation outside traditional hubs to maintain enrollment momentum. Through these measures, organizations demonstrate resilience in the face of policy changes. As market participants anticipate further regulatory developments, a continued focus on strategic agility will be essential to sustain growth and protect patient access to life-changing therapies.

Decoding the Intricate Segmentation Landscape of Shunt and Stent Technologies to Illuminate Innovation Trajectories and Clinical Adoption Patterns

A granular look at the shunt category reveals two distinct design philosophies that guide clinical decision-making. Non-valved systems such as Baerveldt and Molteno rely on the body’s natural tissue response to regulate aqueous outflow over time. These devices often demonstrate durable pressure control in patients with advanced disease, though they require precise surgical expertise to manage early postoperative flow. In contrast, valved constructs exemplified by the Ahmed design incorporate a pressure-sensitive mechanism that mitigates hypotony risk by permitting fluid release only above a predetermined threshold. Surgeons frequently select this option for cases demanding predictable immediate pressure modulation.

Turning to stents, the subconjunctival approach pioneered by XEN has gained recognition for its minimally disruptive insertion technique and consistent reduction in ocular hypertension. Suprachoroidal access embodied by Cypass leverages the space between choroid and sclera to enhance drainage, delivering rapid pressure decreases with a favorable safety profile. Meanwhile, devices targeting the trabecular meshwork, notably Hydrus and iStent, facilitate direct bypass of the eye’s native outflow resistance. These micro-scale scaffolds and bypass implants seamlessly integrate into glaucoma surgery workflows, underscoring the importance of tailored device selection based on anatomical targets and patient-specific factors. As each segment matures, clinicians balance device attributes against individual risk profiles to optimize outcomes.

Assessing Regional Dynamics Across Americas, Europe Middle East Africa, and Asia Pacific to Reveal Growth Drivers and Market Nuances

The Americas region continues to serve as an innovation incubator, underpinned by robust reimbursement frameworks and a dense network of leading academic centers. North American surgeons frequently spearhead clinical trials, leveraging advanced imaging platforms and surgical simulation to refine procedural techniques. Latin American markets, while more price sensitive, display growing demand for devices that can deliver high‐value outcomes with limited resource allocation. Consequently, manufacturers adapt pricing strategies and support programs to address these diverse needs.

Across Europe, the Middle East, and Africa, regulatory harmonization within the European Union has expedited device approvals, fostering an environment conducive to rapid clinical uptake. In the GCC and other emerging economies, private healthcare expansion and rising patient awareness have catalyzed demand for advanced glaucoma solutions. Nevertheless, variations in local health policies necessitate flexible market access plans. Shifting to Asia-Pacific, the region’s large patient populations and expanding ophthalmic infrastructure present substantial opportunities. Countries such as China, Japan, and South Korea combine rigorous domestic research capacity with increasing import volumes, while Southeast Asian nations emphasize cost-effective alternatives. By aligning product roadmaps with these regional characteristics, stakeholders can unlock sustained growth potential.

Profiling Leading Innovators Shaping the Future of Aqueous Shunt and Stent Development Through Strategic Alliances and Technological Leadership

Leading industry innovators continue to shape the trajectory of aqueous shunt and stent development through strategic collaborations and targeted R&D investments. One multinational vision care conglomerate has expanded its microstent portfolio to include advanced luminal coatings that reduce inflammation, while another specialized ophthalmic device company has secured regulatory approvals for a next-generation suprachoroidal implant featuring a proprietary bioadaptive material. Meanwhile, a pioneering firm in the valved shunt space has bolstered its global footprint through distribution agreements and surgeon training initiatives across emerging markets.

In parallel, partnership models are evolving to integrate digital health capabilities. Forward-looking organizations have initiated pilot programs that couple implantable devices with remote monitoring platforms, providing real-time pressure data and personalized postoperative management. These collaborations bridge the gap between surgical expertise and patient engagement, positioning device makers as integral partners in the continuum of care. As competitive pressures intensify, a continued focus on innovation ecosystems and cross-sector alliances will prove decisive for maintaining leadership in the evolving glaucoma treatment paradigm.

Actionable Strategies for Industry Leaders to Capitalize on Emerging Opportunities and Navigate Competitive Pressures in Glaucoma Device Markets

Industry leaders should prioritize deepening investments in next-generation device research that leverages biomimetic materials and smart flow control mechanisms. By aligning R&D roadmaps with emerging clinical evidence and surgeon feedback, organizations can deliver solutions that address unmet patient needs while differentiating offerings in a crowded field. Concurrently, strengthening supply chain resilience through dual-source procurement and near-shoring initiatives will mitigate the impact of geopolitical disruptions and tariff fluctuations.

Furthermore, fostering collaborative relationships with regulatory bodies can expedite review pathways for breakthrough technologies. Early engagement and iterative feedback loops not only accelerate time to market but also enhance post-approval surveillance. On the commercial front, tailored market access strategies that reflect regional reimbursement dynamics and healthcare infrastructure maturity will unlock incremental adoption. Finally, embracing digital health integration-such as remote monitoring and predictive analytics-provides a competitive edge by offering end-to-end patient support. These strategic imperatives will empower stakeholders to navigate evolving market dynamics and realize sustained growth in the glaucoma space.

Unraveling the Rigorous Research Methodology Underpinning Comprehensive Insights Into Aqueous Shunt and Stent Market Dynamics

This analysis employs a rigorous multi-tiered approach to uncover comprehensive insights into the aqueous shunt and stent landscape. Initially, a systematic review of peer-reviewed publications, clinical trial registries, and regulatory filings was conducted to chart the evolution of device technologies and safety profiles. These secondary sources were complemented by patent analysis to identify innovative materials, delivery systems, and proprietary mechanisms under development.

Primary research efforts included in-depth interviews with leading ophthalmic surgeons, device engineers, and reimbursement experts across key markets. Their firsthand perspectives enriched the understanding of real-world adoption barriers, patient selection criteria, and postoperative management protocols. Market dynamics were further validated through cross-referenced revenue data from public financial disclosures and industry reports, ensuring robust triangulation of findings. Finally, a series of scenario planning workshops synthesized these insights to forecast potential pathways for technology adoption, regulatory shifts, and competitive positioning. The result is a cohesive narrative grounded in empirical evidence and expert consensus.

Converging Insights on Aqueous Shunts and Stents to Articulate a Cohesive Vision for Future Glaucoma Care Innovations

The convergence of technological innovation, regulatory evolution, and shifting clinical practices underscores the transformative potential of aqueous shunts and stents in glaucoma care. Through meticulous segmentation analysis, regional evaluation, and company profiling, this report illuminates the intricate factors that will shape market dynamics over the coming years. Stakeholders equipped with these insights are better positioned to refine product portfolios, optimize resource allocation, and pursue strategic collaborations that drive patient-centric outcomes.

As the field continues to mature, the integration of digital health tools, adaptive device architectures, and data-driven performance monitoring will define the next wave of advancements. By embedding agility in their development and commercialization strategies, innovators can not only respond to emerging challenges but also anticipate new avenues for growth. Ultimately, the collective efforts of industry participants will dictate the future trajectory of glaucoma management, with each technological step forward bringing renewed hope to millions affected by this sight-threatening condition.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Shunt
    • Non-Valved
      • Baerveldt
      • Molteno
    • Valved
      • Ahmed
  • Stent
    • Subconjunctival
      • XEN
    • Suprachoroidal
      • Cypass
    • Trabecular Meshwork
      • Hydrus
      • iStent
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Glaukos Corporation
  • Alcon Inc.
  • AbbVie Inc.
  • Ivantis Inc.
  • Carl Zeiss Meditec AG
  • Santen Pharmaceutical Co., Ltd.
  • New World Medical, Inc.
  • iSTAR Medical SA

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of minimally invasive glaucoma surgery with advanced microstent technologies improving patient outcomes
5.2. Integration of drug-eluting features in aqueous shunts to reduce fibrosis and enhance long-term efficacy
5.3. Development of adjustable flow implants allowing personalized aqueous humor drainage modulation
5.4. Rise of biocompatible coatings on glaucoma stents preventing inflammation and extending implant lifespan
5.5. Regulatory approvals in emerging markets accelerating availability and competitive pricing for aqueous implants
5.6. Adoption of implantable glaucoma devices enabling remote intraocular pressure monitoring and telehealth integration
5.7. Strategic partnerships between ophthalmology clinics and device manufacturers creating bundled glaucoma care solutions
5.8. Increasing focus on cost-effectiveness studies influencing payer reimbursement decisions for microstent procedures
5.9. Advancements in imaging-guided insertion techniques boosting precision and reducing surgical complications in glaucoma implants
5.10. Surge in development of next-generation suprachoroidal stents targeting physiological outflow pathways for pressure regulation
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Aqueous Shunts & Stents for Glaucoma Market, by Shunt
8.1. Introduction
8.2. Non-Valved
8.2.1. Baerveldt
8.2.2. Molteno
8.3. Valved
8.3.1. Ahmed
9. Aqueous Shunts & Stents for Glaucoma Market, by Stent
9.1. Introduction
9.2. Subconjunctival
9.2.1. XEN
9.3. Suprachoroidal
9.3.1. Cypass
9.4. Trabecular Meshwork
9.4.1. Hydrus
9.4.2. iStent
10. Americas Aqueous Shunts & Stents for Glaucoma Market
10.1. Introduction
10.2. United States
10.3. Canada
10.4. Mexico
10.5. Brazil
10.6. Argentina
11. Europe, Middle East & Africa Aqueous Shunts & Stents for Glaucoma Market
11.1. Introduction
11.2. United Kingdom
11.3. Germany
11.4. France
11.5. Russia
11.6. Italy
11.7. Spain
11.8. United Arab Emirates
11.9. Saudi Arabia
11.10. South Africa
11.11. Denmark
11.12. Netherlands
11.13. Qatar
11.14. Finland
11.15. Sweden
11.16. Nigeria
11.17. Egypt
11.18. Turkey
11.19. Israel
11.20. Norway
11.21. Poland
11.22. Switzerland
12. Asia-Pacific Aqueous Shunts & Stents for Glaucoma Market
12.1. Introduction
12.2. China
12.3. India
12.4. Japan
12.5. Australia
12.6. South Korea
12.7. Indonesia
12.8. Thailand
12.9. Philippines
12.10. Malaysia
12.11. Singapore
12.12. Vietnam
12.13. Taiwan
13. Competitive Landscape
13.1. Market Share Analysis, 2024
13.2. FPNV Positioning Matrix, 2024
13.3. Competitive Analysis
13.3.1. Glaukos Corporation
13.3.2. Alcon Inc.
13.3.3. AbbVie Inc.
13.3.4. Ivantis Inc.
13.3.5. Carl Zeiss Meditec AG
13.3.6. Santen Pharmaceutical Co., Ltd.
13.3.7. New World Medical, Inc.
13.3.8. iSTAR Medical SA
14. Research AI15. Research Statistics16. Research Contacts17. Research Articles18. Appendix
List of Figures
FIGURE 1. AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 10. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 12. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 18. AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 19. AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET: RESEARCHAI
FIGURE 20. AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET: RESEARCHSTATISTICS
FIGURE 21. AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET: RESEARCHCONTACTS
FIGURE 22. AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY BAERVELDT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY BAERVELDT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY MOLTENO, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY MOLTENO, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY AHMED, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY AHMED, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY XEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY XEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY CYPASS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY CYPASS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY HYDRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY HYDRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY ISTENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY ISTENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 79. CANADA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 80. CANADA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 81. CANADA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 82. CANADA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 83. CANADA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 84. CANADA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 85. CANADA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 86. CANADA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 87. CANADA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 88. CANADA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 89. CANADA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 90. CANADA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 91. CANADA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 92. CANADA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 93. MEXICO AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 94. MEXICO AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 95. MEXICO AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 96. MEXICO AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 97. MEXICO AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 98. MEXICO AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 99. MEXICO AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 100. MEXICO AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 101. MEXICO AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 102. MEXICO AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 103. MEXICO AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 104. MEXICO AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 105. MEXICO AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 106. MEXICO AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 165. GERMANY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 166. GERMANY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 167. GERMANY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 168. GERMANY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 169. GERMANY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 170. GERMANY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 171. GERMANY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 172. GERMANY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 173. GERMANY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 174. GERMANY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 175. GERMANY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 176. GERMANY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 177. GERMANY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 178. GERMANY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 179. FRANCE AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 180. FRANCE AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 181. FRANCE AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 182. FRANCE AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 183. FRANCE AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 184. FRANCE AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 185. FRANCE AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 186. FRANCE AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 187. FRANCE AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 188. FRANCE AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 189. FRANCE AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 190. FRANCE AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 191. FRANCE AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 192. FRANCE AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 207. ITALY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 208. ITALY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 209. ITALY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 210. ITALY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 211. ITALY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 212. ITALY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 213. ITALY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 214. ITALY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 215. ITALY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 216. ITALY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 217. ITALY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 218. ITALY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 219. ITALY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 220. ITALY AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 221. SPAIN AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 222. SPAIN AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 223. SPAIN AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 224. SPAIN AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 225. SPAIN AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 226. SPAIN AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 227. SPAIN AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 228. SPAIN AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 229. SPAIN AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 230. SPAIN AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 231. SPAIN AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 232. SPAIN AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 233. SPAIN AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 234. SPAIN AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 250. SAUDI ARABIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 252. SAUDI ARABIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 254. SAUDI ARABIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 256. SAUDI ARABIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 258. SAUDI ARABIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 264. SOUTH AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 266. SOUTH AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 267. SOUTH AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 268. SOUTH AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 269. SOUTH AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 270. SOUTH AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 272. SOUTH AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 277. DENMARK AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 278. DENMARK AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 279. DENMARK AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 280. DENMARK AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 281. DENMARK AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 282. DENMARK AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2025-2030 (USD MILLION)
TABLE 283. DENMARK AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2018-2024 (USD MILLION)
TABLE 284. DENMARK AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY STENT, 2025-2030 (USD MILLION)
TABLE 285. DENMARK AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2018-2024 (USD MILLION)
TABLE 286. DENMARK AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUBCONJUNCTIVAL, 2025-2030 (USD MILLION)
TABLE 287. DENMARK AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2018-2024 (USD MILLION)
TABLE 288. DENMARK AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SUPRACHOROIDAL, 2025-2030 (USD MILLION)
TABLE 289. DENMARK AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2018-2024 (USD MILLION)
TABLE 290. DENMARK AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY TRABECULAR MESHWORK, 2025-2030 (USD MILLION)
TABLE 291. NETHERLANDS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2018-2024 (USD MILLION)
TABLE 292. NETHERLANDS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY SHUNT, 2025-2030 (USD MILLION)
TABLE 293. NETHERLANDS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2018-2024 (USD MILLION)
TABLE 294. NETHERLANDS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY NON-VALVED, 2025-2030 (USD MILLION)
TABLE 295. NETHERLANDS AQUEOUS SHUNTS & STENTS FOR GLAUCOMA MARKET SIZE, BY VALVED, 2018-2024 (USD MILLION)
TABLE 296. NETHERLANDS AQUEOUS SHUNTS & STENTS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Aqueous Shunts & Stents for Glaucoma Market report include:
  • Glaukos Corporation
  • Alcon Inc.
  • AbbVie Inc.
  • Ivantis Inc.
  • Carl Zeiss Meditec AG
  • Santen Pharmaceutical Co., Ltd.
  • New World Medical, Inc.
  • iSTAR Medical SA

Related Topics

Related Reports

Aqueous Shunts and Stents for Glaucoma Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Aqueous Shunts and Stents for Glaucoma Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 95 Pages
  • Global
From
Micro Invasive Glaucoma Surgery (MIGS) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Micro Invasive Glaucoma Surgery (MIGS) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Glaucoma Drainage Devices Market by Device Type (Minimally Invasive Glaucoma Surgery Device, Tube Shunt), Surgery Approach (Ab Externo, Ab Interno), End User, Port Design, Material, Distribution Channel - Global Forecast 2025-2030 - Product Image

Glaucoma Drainage Devices Market by Device Type (Minimally Invasive Glaucoma Surgery Device, Tube Shunt), Surgery Approach (Ab Externo, Ab Interno), End User, Port Design, Material, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Glaucoma Implant Device Market by Product Type (Minimally Invasive, Nonvalved, Valved), Glaucoma Type (Angle Closure, Open Angle, Secondary), End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Glaucoma Implant Device Market by Product Type (Minimally Invasive, Nonvalved, Valved), Glaucoma Type (Angle Closure, Open Angle, Secondary), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Minimally Invasive Glaucoma Surgery Devices Market by Mechanism (Canaloplasty, Subconjunctival Filtration, Suprachoroidal Shunts), End User (Ambulatory Surgery Centers, Hospital, Ophthalmic Clinics), Distribution Channel, Indication - Global Forecast 2025-2030 - Product Image

Minimally Invasive Glaucoma Surgery Devices Market by Mechanism (Canaloplasty, Subconjunctival Filtration, Suprachoroidal Shunts), End User (Ambulatory Surgery Centers, Hospital, Ophthalmic Clinics), Distribution Channel, Indication - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.